Elsevier

Neuropeptides

Volume 83, October 2020, 102075
Neuropeptides

News and Reviews
Role of neurotrophins in pregnancy and offspring brain development

https://doi.org/10.1016/j.npep.2020.102075Get rights and content

Highlights

  • The review describes the role of neurotrophins in pregnancy and brain development.

  • Influence of maternal nutrition on neurotrophins and neuropeptides is discussed.

  • It discusses clues towards improving cognitive performance in children.

Abstract

Neurotrophins are a family of functionally and structurally related proteins which play a key role in the survival, development, and function of neurons in both the central and peripheral nervous systems. Brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) are the family members of neurotrophins. Neurotrophins play a crucial role in influencing the development of the brain and learning and memory processes. Studies demonstrate that they also play crucial role in influencing reproductive and immune systems. Neurotrophins have been shown to influence various processes in the mother, placenta, and fetus during pregnancy. Development and maturation of feto-placental unit and the fetal growth trajectories are influenced by neurotrophins.

In addition to neurotrophins, neuropeptides like neuropeptide Y also play a crucial role during various processes of pregnancy and during fetal brain development. Neurotrophins have also been shown to have a cross talk with various angiogenic factors and influence placental development. Alterations in the levels of neurotrophins and neuropeptides lead to placental pathologies resulting in various pregnancy complications like preeclampsia, intrauterine growth restriction and preterm births. Studies in animals have reported low levels of maternal micronutrients like folic acid, vitamin B12 and omega-3 fatty acids influence brain neurotrophins resulting in impaired cognitive functioning in the offspring. Maternal nutrition is also known to affect the expression of neuropeptides. It is essential to understand the role of various neurotrophins across various stages of pregnancy and its relationship with neurodevelopmental outcomes in children. This will lead to early prediction of poor neurodevelopmental outcomes. The present review describes evidence describing the role of neurotrophins in determining pregnancy outcome and altered neurodevelopment in the offspring. The possible mechanism through which maternal nutrition influences neurotrophins and neuropeptides to regulate offspring brain development and function is also discussed.

Introduction

Neurotrophins are a family of growth factors which play a key role in the differentiation, growth and survival of neuronal as well as non-neuronal cells (Huang and Reichardt, 2001). They include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) (Lee et al., 2001). NGF is expressed in both neuronal and non-neuronal cells of the central and peripheral nervous system (Sofroniew et al., 2001). Various regions of the brain such as hippocampus, cortex and pituitary gland are suggested to have the highest NGF expression (Aloe et al., 2012; West et al., 2014) while BDNF is expressed in the hippocampus, cortex, cerebellum and amygdala (Adachi et al., 2014).

The biological functions of neurotrophins are mediated by high affinity tyrosine kinase receptors (trk) which play a major role in the biological functions of neurotrophic target cells and low affinity receptor p75 (Hempstead, 2002). NGF exerts its effects by binding to the trkA receptor located on the cell surface (Huang and Reichardt, 2003; Molloy et al., 2011; Vera et al., 2014) which activates the cytosolic/endosomal pathways such as PI3K, phospholipase C and ras-mitogen activated protein kinase (MAPK) (Klesse and Parada, 1999; Reichardt, 2006). BDNF binds to its high affinity receptor trkB as well as to p75NTR with low affinity (Barbacid, 1994). NT-3 binds with a greater affinity to trkC and lesser affinity to trkB (Razavi et al., 2015) whereas NT-4 binds with trkB (Bothwell, 2014).

During the past few years various studies have demonstrated the involvement of neurotrophins in various processes during pregnancy (Bienertova-Vasku et al., 2013; Frank et al., 2014). In the mother, neurotrophins are involved in regulating implantation, maternal immunity and modulating vascular growth (Toti et al., 2006). Neurotrophins like NGF and BDNF play an important role in placental development and maturation (Kawamura et al., 2007; D'Angelo et al., 2020). Neurotrophins are also termed as “angioneurins” as they regulate angiogenesis (Zacchigna et al., 2008). During embryogenesis, BDNF and NT-3 play an important role in angiogenesis and vessel stabilization (Kermani and Hempstead, 2007). Angiogenesis may be directly induced by NGF via its receptor or indirectly through vascular endothelial growth factor, an angiogenic factor (Nico et al., 2008). Studies from our group have demonstrated altered levels of neurotrophins like NGF and BDNF in preeclampsia (V. A. D’Souza et al., 2014b, Sahay et al., 2015).

Neurotrophins may influence angiogenic processes through various neuropeptides. This may have implications in pregnancy specific disorders such as preeclampsia which is characterized by impaired angiogenesis and increased blood pressure. Neuropeptides such as angiotensin-II, has been shown to influence angiogenesis along with its receptors ang II type 1 receptor (AT1R) and type 2 receptor (AT2R) and regulates blood pressure (Gallo-Payet et al., 2011; Guimond and Gallo-Payet, 2012). We have earlier demonstrated higher concentrations of angiotensin II type 1 receptor auto-antibodies (AT1R-AA), which are auto-antibodies against angiotensin II receptor type 1 (AT1R) in women with preeclampsia (Sahay et al., 2014). Another neuropeptide, Neuropeptide Y (NPY) has also been reported to be involved in elevating the blood pressure (Tan et al., 2018). A recent study reports reduced expression of NPY receptor in women with preeclampsia which may be associated with abnormalities of placental angiogenesis (Klinjampa and Sitticharoon, 2019).

Neurotrophins like BDNF cross the utero-placental barrier to reach the fetal brain (Kodomari et al., 2009). They are involved in prenatal and postnatal development of the brain and have neuroprotective action (Nikolaou et al., 2006). Neurotrophins have been shown to modulate the expression of neuropeptides like neuropeptide W in neuronal cells via the PI3K/Akt pathway (Wang et al., 2017). Both neurotrophins and neuropeptides have been shown to play an important role in influencing synaptic properties in the developing and the mature nervous system (Zagrebelsky and Korte, 2014; Catalani et al., 2017).

Various intrauterine factors such as maternal nutrition during pregnancy influence fetal brain plasticity and neurodevelopment (Lindsay et al., 2019). Our studies in rats have demonstrated that a combined supplementation of n-3 poly unsaturated fatty acids (PUFA) and vitamin B12 improve the concentrations of neurotrophins like BDNF and NGF in the brain leading to improved neurovascular function and brain development (Rathod et al., 2015; Rathod et al., 2016). Brain neurotrophins are also influenced by a maternal diet with high levels of folate and low vitamin B12 resulting in lowered cognitive function in the offspring (Sable et al., 2011; Sable et al., 2012). In another study, mice fed a high fat diet had reduced expression of BDNF, NGF and NT-4/5 in the offspring brain leading to impaired neurogenesis and synaptic plasticity (Bae-Gartz et al., 2019). Rats fed a high fat diet are reported to reduce NPY 1 receptor and BDNF in the hippocampus and frontal cortex increasing the vulnerability for anxiety-like behaviour (Sharma et al., 2012). A study in rats also demonstrates that omega-3 deficient diet decreases NPY 1 receptor and BDNF in the hypothalamus and hippocampus of male offspring rats (Bhatia et al., 2011). However, these limited studies in animals report the influence of maternal diet either on the concentrations of neurotrophins or neuropeptides in the offspring brain. To the best of our knowledge there are no studies which have examined the role of maternal nutrition in regulating neurotrophins and neuropeptides to influence pregnancy outcome and offspring brain development. It is likely that during pregnancy, maternal nutrition influences the levels and expression of neurotrophins and neuropeptides thereby regulating angiogenesis and influencing placental and brain development (Fig. 1).

The present review summarizes the studies on neurotrophins in pregnancy and brain development and discusses the possible mechanism through which maternal nutrition can influence neurotrophins and neuropeptides to influence pregnancy outcome and offspring brain development.

Section snippets

Role of neurotrophins during pregnancy

Implantation of the embryo marks the initiation of pregnancy, wherein the embryo adheres to the endometrial surface of the uterus (Kim and Kim, 2017). Neurotrophins like BDNF and neurotrophin-3 have been suggested to be involved during the preimplantation stage as well as early embryonic development (Kawamura et al., 2007; Bernd, 2008). Reduced serum BDNF levels have been reported early in an IVF cycle in women having ectopic pregnancy or spontaneous abortion as compared to women who gave live

Neurotrophins and pregnancy complications

Alterations in the levels of neurotrophins leads to placental pathologies resulting in various pregnancy complications like preeclampsia, gestational diabetes mellitus (GDM), preterm births, and intrauterine growth restriction (Mayeur et al., 2010; Dhobale et al., 2013; Dhobale, 2014; Sahay et al., 2015; Briana et al., 2018). Table 1 and Table 2 summarize various human studies examining NGF and BDNF in these pregnancy complications. These studies demonstrate that a balanced expression of

Role of neuropeptides in pregnancy

During pregnancy, neuropeptides like melatonin, urocortin, oxytocin and serotonin play an important role in processes like placental development, appetite regulation, regulation of hormones like estrogen and in the process of parturition (Vitale et al., 2016; Kim et al., 2017; Napso et al., 2018; Hudon Thibeault et al., 2019). Although there are many neuropeptides as discussed above, which are involved in various processes throughout pregnancy, the section below focuses on kisspeptins and

Role of neurotrophins during brain development

Differentiation of the neural progenitor cells in the third week of gestation begins the brain development of the fetus (Stiles and Jernigan, 2010). Processes of neuronal growth and differentiation in peripheral and central nervous system of a developing fetus involve neurotrophins like BDNF and NGF (Tometten et al., 2005; Garces et al., 2014; Bathina and Das, 2015). BDNF has been suggested to be the key regulator of the neural circuit development in the central nervous system, where it is

Neuropeptide Y and brain development

NPY is one of the most abundant neuropeptides in the central and peripheral nervous system and is involved in various functions in the brain including neurogenesis, neuroprotection and neuroinflammation (Malva et al., 2012). These are widely distributed in brain regions such as hippocampus, amygdala and the basal forebrain responsible for learning and memory processes (Borbély et al., 2013). It is a neurotransmitter whose proliferative effects are mediated via G protein-coupled receptors - Y1R,

Preeclampsia and offspring brain neurodevelopment

Offspring exposed to hypertensive disorders of pregnancy like preeclampsia have increased risk of developing neurodevelopmental disorders like attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) (Nomura et al., 2017; Maher et al., 2018). Children with ASD are twice as likely to have been exposed to preeclampsia in utero as compared to controls indicating that systemic inflammation, faulty placentation, nutrient transfer restriction and oxidative stress influence

Possible mechanism through which maternal nutrition influences neurotrophins and neuropeptides thereby regulating offspring brain development and function

Maternal nutritional status plays a major role in determining pregnancy outcome and fetal well being (Morrison and Regnault, 2016). Imbalanced maternal nutrition is suggested to have an association with pregnancy complications like preeclampsia (Baker et al., 2018). Micronutrients such as vitamin B12 and folate are important regulators of the one carbon cycle and influence pregnancy outcome resulting in intrauterine programming of diseases in the offspring in later life (Yajnik and Deshmukh,

Conclusion

Neurotrophins are involved in placental and fetal brain development. Further, their expression is altered in complications of pregnancy such as preeclampsia. Maternal nutrition affects the levels and expression of these neurotrophins which may regulate fetal brain growth and development possibly through alterations in the concentrations of neuropeptides. In order to better understand the role of maternal nutrition on plasma and placental neurotrophins our group has initiated a study (REVAMP

Declaration of Competing Interest

The authors declare that they have no conflict of interest.

Acknowledgement

The authors thank the Indian Council of Medical Research for funding the REVAMP study (5/7/1069/13-RCH). Author AS thanks the Indian Council of Medical Research (ICMR), Government of India for providing her the ‘RA fellowship’ (RBMH/FW/2019/17).

References (147)

  • V. D'Souza et al.

    Maternal nerve growth factor levels during pregnancy in women with preeclampsia: A longitudinal study

    Int. J. Dev. Neurosci.

    (2015 Dec)
  • A. Flöck et al.

    Determinants of brain-derived neurotrophic factor (BDNF) in umbilical cord and maternal serum

    Psychoneuroendocrinology

    (2016)
  • K. Fujita et al.

    Differential expression and the anti-apoptotic effect of human placental neurotrophins and their receptors

    Placenta

    (2011)
  • C.R. Gøtzsche et al.

    The role of NPY in learning and memory

    Neuropeptides

    (2016)
  • B.L. Hempstead

    The many faces of p75NTR

    Curr. Opin. Neurobiol.

    (2002)
  • K.L. Hu et al.

    Kisspeptin as a potential biomarker throughout pregnancy

    Eur. J. Obstet. Gynecol. Reprod. Biol.

    (2019)
  • A.A. Hudon Thibeault et al.

    Serotonin-estrogen interactions: what can we learn from pregnancy?

    Biochimie

    (2019)
  • A. Ilhan et al.

    Plasma neuropeptide Y levels differ in distinct diabetic conditions

    Neuropeptides

    (2010)
  • L. Iughetti et al.

    Brain-derived neurotrophic factor and epilepsy: a systematic review

    Neuropeptides

    (2018)
  • K. Kawamura et al.

    Regulation of preimplantation embryo development by brain-derived neurotrophic factor

    Dev. Biol.

    (2007)
  • P. Kermani et al.

    Brain-derived neurotrophic factor: a newly described mediator of angiogenesis

    Trends Cardiovasc. Med.

    (2007)
  • S. Khatun et al.

    Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia

    Am. J. Obstet. Gynecol.

    (2000)
  • S.H. Kim et al.

    Advances in the role of oxytocin receptors in human parturition

    Mol. Cell. Endocrinol.

    (2017)
  • I. Kodomari et al.

    Maternal supply of BDNF to mouse fetal brain through the placenta

    Neurochem. Int.

    (2009)
  • V. Kormos et al.

    Role of neuropeptides in anxiety, stress, and depression: from animals to humans

    Neuropeptides

    (2013)
  • S. Kovac et al.

    Neuropeptides in epilepsy

    Neuropeptides

    (2013)
  • A.V. Kulkarni et al.

    Reduced placental docosahexaenoic acid levels associated with increased levels of sFlt-1 in preeclampsia

    Prostaglandins Leukot. Essent. Fat. Acids

    (2011)
  • K. Kumazaki et al.

    Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions

    Hum Pathol

    (2002)
  • F.S. Lee et al.

    The uniqueness of being a neurotrophin receptor

    Curr. Opin. Neurobiol.

    (2001)
  • S. Lin et al.

    NPY and Y receptors: lessons from transgenic and knockout models

    Neuropeptides

    (2004)
  • K.L. Lindsay et al.

    The interplay between nutrition and stress in pregnancy: implications for Fetal programming of Brain development

    Biol. Psychiatry

    (2019)
  • S. Liu et al.

    Neuropeptide Y stimulates osteoblastic differentiation and VEGF expression of bone marrow mesenchymal stem cells related to canonical Wnt signaling activating in vitro

    Neuropeptides

    (2016)
  • A. Malamitsi-Puchner et al.

    Perinatal changes of brain-derived neurotrophic factor in pre- and fullterm neonates

    Early Hum. Dev.

    (2004)
  • A. Malamitsi-Puchner et al.

    Intrauterine growth restriction and circulating neurotrophin levels at term

    Early Hum. Dev.

    (2007)
  • J.O. Malva et al.

    Multifaces of neuropeptide Y in the brain--neuroprotection, neurogenesis and neuroinflammation

    Neuropeptides

    (2012)
  • S. Mayeur et al.

    Placental BDNF/TrkB signaling system is modulated by fetal growth disturbances in rat and human

    Placenta

    (2010)
  • S. Mayeur et al.

    Do neurotrophins regulate the feto-placental development?

    Med. Hypotheses

    (2011)
  • T.M. Mayhew

    Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells

    Placenta

    (2002)
  • Y. Muroi et al.

    A novel neuropeptide Y neuronal pathway linking energy state and reproductive behavior

    Neuropeptides

    (2016)
  • B. Nico et al.

    Nerve growth factor as an angiogenic factor

    Microvasc. Res.

    (2008)
  • S.P. Paiva et al.

    Elevated levels of neuropeptide Y in preeclampsia: a pilot study implicating a role for stress in pathogenesis of the disease

    Neuropeptides

    (2016)
  • L.O. Perucci et al.

    Decreased plasma concentrations of brain-derived neurotrophic factor in preeclampsia

    Clin. Chim. Acta

    (2017)
  • N. Adachi et al.

    New insight in expression, transport, and secretion of brain-derived neurotrophic factor: implications in brain-related diseases

    World J. Biol. Chem.

    (2014)
  • L. Aloe et al.

    Nerve growth factor: from the early discoveries to the potential clinical use

    J. Transl. Med.

    (2012)
  • N. Antonakopoulos et al.

    Association between Brain-derived neurotrophic factor (BDNF) levels in 2(nd) trimester amniotic fluid and Fetal development

    Mediat. Inflamm.

    (2018)
  • Y. Ardiani et al.

    Differences in Brain-derived neurotrophic factor and matrix Metalloproteinase-9 between appropriate neonates between Normal birth weight and intrauterine growth restriction

    Open Access Macedonian J. Med. Sci.

    (2019)
  • I. Bae-Gartz et al.

    Maternal obesity alters Neurotrophin-associated MAPK Signaling in the hypothalamus of male mouse offspring

    Front. Neurosci.

    (2019)
  • B.C. Baker et al.

    Effects of micronutrients on placental function: evidence from clinical studies to animal models

    Reproduction

    (2018)
  • M. Barbacid

    The Trk family of neurotrophin receptors

    J. Neurobiol.

    (1994)
  • S. Bathina et al.

    Brain-derived neurotrophic factor and its clinical implications

    Arch. Med. Sci.

    (2015)
  • Cited by (31)

    • Critical windows of early-life microbiota disruption on behaviour, neuroimmune function, and neurodevelopment

      2023, Brain, Behavior, and Immunity
      Citation Excerpt :

      Although we analysed a range of genes based on previous findings of microbial gene regulation in the amygdala, the impact of our intervention was limited to two genes associated with neuroplasticity and neuroimmunity in adolescence: Bdnf and Il-6. For instance, altered Bdnf expression is a hallmark of a perturbed microbiota-gut-brain axis, and alterations have been observed in models of germ-free, antibiotic-depletion, depression, and neurodevelopmental disorders (Suda and Matsuda, 2022; Sahay et al., 2020). Further, increased expression of proinflammatory Il-6 has been associated with autism, and anxiety-like and depressive behaviours (Wei et al., 2013).

    • Altered levels of neurobiological biomarkers at the interface of depression and gestational diabetes mellitus in Asian Indian women

      2022, Neuropeptides
      Citation Excerpt :

      Stimulation of the HPA axis is believed to decrease the production of brain-derived neurotrophic factor (BDNF), and reduced BDNF level has been associated with the severity of depression (Naveen et al., 2016). BDNF has also been studied in the context of pregnancy outcome and pregnancy complications (Sahay et al., 2020). A recent study by Christian et al., (Christian et al., 2016) examined the BDNF levels across pregnancy and reported that serum BDNF levels were declined considerably from the 1st to 3rd trimester and associated with lower birth weight.

    • Maternal urban particulate matter exposure and signaling pathways in fetal brains and neurobehavioral development in offspring

      2022, Toxicology
      Citation Excerpt :

      Human placental serotonergic and neurotrophic signaling can be disrupted by PM2.5 exposure during pregnancy (Behura et al., 2019). Proteins involved in these pathways, such as serotonin and Brain-derived neurotrophic factor (BDNF), play an important role in the development of the fetal nervous system during pregnancy (Bonnin and Levitt, 2011; Rosenfeld, 2020; Sahay et al., 2020). Thus, the role of the placenta in mediating the effects of prenatal PM exposure on fetal brain development warrants further investigation.

    • Folic acid alleviates the blood brain barrier permeability and oxidative stress and prevents cognitive decline in sepsis-surviving rats

      2021, Microvascular Research
      Citation Excerpt :

      FA is a cofactor in one‑carbon metabolism that promotes the restoration of methionine from homocysteine-mediated preservation of neuronal integrity and has been shown to have antioxidant activity (Pope et al., 2019). FA has also been shown to prevent memory deficit and the reduction in BDNF levels induced by homocysteine injection (Sahay et al., 2020). Additionally, it is recognized for a neuroprotective effect in different preclinical studies (Djuric et al., 2007; Marković et al., 2011; Rasic-Markovic et al., 2015; Rasic-Markovic et al., 2016).

    • Long term neuroprotective effects of acute single dose MK-801treatment against traumatic brain injury in immature rats

      2021, Neuropeptides
      Citation Excerpt :

      The loss of hippocampal neuron cells is generally noticed after TBI and thought to be associated with learning and memory loss (Smith et al., 1994). Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) are both factors of the neurotrophin family and were originally identified as neuronal survival factors (Barde et al., 1982; Sahay et al., 2020). In addition to supporting the proliferation and differentiation of neurons, they also affect the shape and number of dendritic spines, a critical determinant of neural computing capacity (Cohen et al., 2010; Kuczewski et al., 2010; Autry and Monteggia, 2012; He et al., 2013).

    View all citing articles on Scopus
    View full text